Neoimmunetech Polandsp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2024-05-10
Share capital
300,000.00 PLN
Registered address
ul. Dzwonkowa 104, 43-100 Tychy, Poland
Electronic delivery address
AE:PL-53283-80720-DVFFE-17
Financials
Revenue history
Filing timeliness
Financial statements were filed on time, on average 66 days early.
- 202524/04/2026
- 202427/05/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.00kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD -41.37kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 23.16kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 267.07kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Tae Woo Kim – President of the Management Board
Manner of representation
Each member of the management board may represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Neoimmunetech, Inc. | 6,000 | $81,037.28 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-10-21.
42 1030 1508 0000 0008 2386 6000
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Passio Human Microbiomesp. z o.o. | $1,856.58 | passiohumanmicrobiome.com | ||
| Dairy Biotechnologiessp. z o.o. | $1,485.09 | milcu.eu | ||
| Medical Algorithmssp. z o.o. | $682.08 | medicalalgorithms.eu | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com | ||
| Codagenesp. z o.o. | – | codagene.com |
FAQ
The main business activity of Neoimmunetech Poland focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on May 10, 2024.
The headquarters is located at: ul. Dzwonkowa 104, 43-100 Tychy.
The share capital of the company is PLN 300,000 (approx. $81,037).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $1,005 in 2025, which is an increase of 680.9% compared to 2024.
No, in 2025 the company was not profitable, reporting a net loss of $41,369. For comparison, in 2024 the loss was $14,996, meaning the company increased its loss by 175.2%.
The largest operating cost category falls under external services. This category amounted to $19,508 in 2025, representing 84% of all operating expenses.
Last updated: 2026-10-07